Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters










Publication year range
1.
Nat Chem ; 13(2): 140-148, 2021 02.
Article in English | MEDLINE | ID: mdl-33380742

ABSTRACT

Finding faster and simpler ways to screen protein sequence space to enable the identification of new biocatalysts for asymmetric synthesis remains both a challenge and a rate-limiting step in enzyme discovery. Biocatalytic strategies for the synthesis of chiral amines are increasingly attractive and include enzymatic asymmetric reductive amination, which offers an efficient route to many of these high-value compounds. Here we report the discovery of over 300 new imine reductases and the production of a large (384 enzymes) and sequence-diverse panel of imine reductases available for screening. We also report the development of a facile high-throughput screen to interrogate their activity. Through this approach we identified imine reductase biocatalysts capable of accepting structurally demanding ketones and amines, which include the preparative synthesis of N-substituted ß-amino ester derivatives via a dynamic kinetic resolution process, with excellent yields and stereochemical purities.


Subject(s)
High-Throughput Screening Assays/methods , Oxidoreductases/isolation & purification , Amination/drug effects , Amines/chemistry , Biocatalysis , Imines/metabolism , Ketones/chemistry , Oxidoreductases/metabolism , Stereoisomerism
2.
ChemMedChem ; 15(4): 370-375, 2020 02 17.
Article in English | MEDLINE | ID: mdl-31774938

ABSTRACT

Innovative and efficient hit-identification techniques are required to accelerate drug discovery. Protein-templated fragment ligations represent a promising strategy in early drug discovery, enabling the target to assemble and select its binders from a pool of building blocks. Development of new protein-templated reactions to access a larger structural diversity and expansion of the variety of targets to demonstrate the scope of the technique are of prime interest for medicinal chemists. Herein, we present our attempts to use a protein-templated reductive amination to target protein-protein interactions (PPIs), a challenging class of drug targets. We address a flexible pocket, which is difficult to achieve by structure-based drug design. After careful analysis we did not find one of the possible products in the kinetic target-guided synthesis (KTGS) approach, however subsequent synthesis and biochemical evaluation of each library member demonstrated that all the obtained molecules inhibit MDM2. The most potent library member (Ki =0.095 µm) identified is almost as active as Nutlin-3, a potent inhibitor of the p53-MDM2 PPI.


Subject(s)
Aldehydes/pharmacology , Enzyme Inhibitors/pharmacology , Proto-Oncogene Proteins c-mdm2/antagonists & inhibitors , Aldehydes/chemical synthesis , Aldehydes/chemistry , Amination/drug effects , Dose-Response Relationship, Drug , Drug Discovery , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/chemistry , Humans , Molecular Docking Simulation , Molecular Structure , Protein Binding/drug effects , Proto-Oncogene Proteins c-mdm2/metabolism , Structure-Activity Relationship
3.
Eur J Pharm Biopharm ; 91: 75-81, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25661588

ABSTRACT

Using a novel two-step approach, the thiolation of gelatin for mucoadhesive drug delivery has been achieved. The initial step involved the amination of native gelatin via an amine to carboxylic acid coupling reaction with ethylene diamine, followed by thiolation with Traut's reagent. The resulting thiolated product showed an increase in thiol content of up to 10-fold in comparison with control gelatin samples. Improved cohesion and mucoadhesion in comparison with unmodified and control gelatin samples was also observed. This reaction process was observed to be influenced by both the temperature and the pH of the amination reaction, affecting both amine content and product yield. Swelling ability, cohesion and mucoadhesion were all observed to be strongly dependent on the thiol content of the samples but also, importantly, the molecular weight (MW) of the gelatin used. Gelatin with a MW of 20-25 kDa proved to be optimal in creating this novel mucoadhesive gelatin material.


Subject(s)
Drug Delivery Systems , Gelatin/chemistry , Intestinal Mucosa/metabolism , Polymers/chemistry , Sulfhydryl Compounds/chemistry , Adhesiveness , Amination/drug effects , Animals , Cattle , Cross-Linking Reagents/chemistry , Cross-Linking Reagents/pharmacology , Ethylenediamines/chemistry , Ethylenediamines/pharmacology , Gelatin/metabolism , Hot Temperature , Hydrogen-Ion Concentration , Imidoesters/chemistry , Imidoesters/pharmacology , Indicators and Reagents/chemistry , Indicators and Reagents/pharmacology , Microscopy, Electron, Scanning , Molecular Weight , Polymers/chemical synthesis , Sulfhydryl Compounds/chemical synthesis , Surface Properties , Sus scrofa , Water/analysis
4.
PLoS One ; 9(6): e97454, 2014.
Article in English | MEDLINE | ID: mdl-24893046

ABSTRACT

The scleractinian coral Acropora millepora is one of the most studied species from the Great Barrier Reef. This species has been used to understand evolutionary, immune and developmental processes in cnidarians. It has also been subject of several ecological studies in order to elucidate reef responses to environmental changes such as temperature rise and ocean acidification (OA). In these contexts, several nucleic acid resources were made available. When combined to a recent proteomic analysis of the coral skeletal organic matrix (SOM), they enabled the identification of several skeletal matrix proteins, making A. millepora into an emerging model for biomineralization studies. Here we describe the skeletal microstructure of A. millepora skeleton, together with a functional and biochemical characterization of its occluded SOM that focuses on the protein and saccharidic moieties. The skeletal matrix proteins show a large range of isoelectric points, compositional patterns and signatures. Besides secreted proteins, there are a significant number of proteins with membrane attachment sites such as transmembrane domains and GPI anchors as well as proteins with integrin binding sites. These features show that the skeletal proteins must have strong adhesion properties in order to function in the calcifying space. Moreover this data suggest a molecular connection between the calcifying epithelium and the skeletal tissue during biocalcification. In terms of sugar moieties, the enrichment of the SOM in arabinose is striking, and the monosaccharide composition exhibits the same signature as that of mucus of acroporid corals. Finally, we observe that the interaction of the acetic acid soluble SOM on the morphology of in vitro grown CaCO3 crystals is very pronounced when compared with the calcifying matrices of some mollusks. In light of these results, we wish to commend Acropora millepora as a model for biocalcification studies in scleractinians, from molecular and structural viewpoints.


Subject(s)
Anthozoa/anatomy & histology , Anthozoa/metabolism , Bone and Bones/anatomy & histology , Bone and Bones/metabolism , Acetic Acid/pharmacology , Amination/drug effects , Animals , Anthozoa/drug effects , Anthozoa/ultrastructure , Bone and Bones/drug effects , Bone and Bones/ultrastructure , Calcium Carbonate/metabolism , Crystallization , Gels , Monosaccharides/analysis , Proteins/metabolism , Solubility , Spectroscopy, Fourier Transform Infrared , Spectrum Analysis, Raman
5.
Prikl Biokhim Mikrobiol ; 49(2): 190-6, 2013.
Article in English | MEDLINE | ID: mdl-23795479

ABSTRACT

The physiology of feeding ammonium sulphate in erythromycin biosynthesis phase of Saccharopolyspora erythraea on the regulation of erythromycin A (Er-A) biosynthesis was investigated in 50 L fermenter. At an optimal feeding ammonium sulphate rate of 0.03 g/L per h, the maximal Er-A production was 8281 U/mL at 174 h of growth, which was increased by 26.3% in comparison with the control (6557 U/mL at 173 h). Changes in cell metabolic response of actinomycete were observed, i.e. there was a drastic increase in the level of carbon dioxide evolution rate and oxygen consumption. Assays of the key enzyme activities and organic acids of S. erythraea and amino acids in culture broth revealed that cell metabolism was enhanced by ammonium assimilation, which might depend on the glutamate transamination pathway. The enhancement of cell metabolism induced an increase of the pool of TCA cycle and the metabolic flux of erythromycin biosynthesis. In general, ammonium assimilation in the erythromycin biosynthesis phase of S. erythraea exerted a significant impact on the carbon metabolism and formation of precursors of the process for dramatic regulation of secondary metabolites biosynthesis.


Subject(s)
Ammonium Sulfate/metabolism , Erythromycin/biosynthesis , Saccharopolyspora/metabolism , Amination/drug effects , Amino Acids/metabolism , Ammonium Sulfate/pharmacology , Bioreactors , Carbon Dioxide/metabolism , Citric Acid Cycle/drug effects , Fermentation/drug effects , Glutamic Acid/metabolism , Oxygen/metabolism , Saccharopolyspora/drug effects
6.
J Biotechnol ; 154(1): 1-10, 2011 Jun 10.
Article in English | MEDLINE | ID: mdl-21540064

ABSTRACT

Pseudomonas putida S12 is a promising platform organism for the biological production of substituted aromatic compounds due to its extreme tolerance towards toxic chemicals. Solvent or aromatic stress tolerance may be due to membrane modifications and efflux pumps; however in general, polyamines have also been implicated in stressed cells. Previous transcriptomics results of P. putida strains producing an aromatic compound, or being exposed to the solvent toluene, indicated differentially expressed genes involved in polyamine transport and metabolism. Therefore, the metabolism of the polyamine, putrescine was investigated in P. putida S12, as no putrescine degradation pathways have been described for this strain. Via transcriptome analysis various, often redundant, putrescine-induced genes were identified as being potentially involved in putrescine catabolism via oxidative deamination and transamination. A series of knockout mutants were constructed in which up to six of these genes were sequentially deleted, and although putrescine degradation was affected in some of these mutants, complete elimination of putrescine degradation in P. putida S12 was not achieved. Evidence was found for the presence of an alternative pathway for putrescine degradation involving γ-glutamylation. The occurrence of multiple putrescine degradation routes in the solvent-tolerant P. putida S12 is indicative of the importance of controlling polyamine homeostasis, as well as of the high metabolic flexibility exhibited by this microorganism.


Subject(s)
Adaptation, Physiological/drug effects , Pseudomonas putida/drug effects , Pseudomonas putida/metabolism , Putrescine/metabolism , Solvents/pharmacology , Adaptation, Physiological/genetics , Amination/drug effects , Biological Transport/drug effects , Biological Transport/genetics , Chloramphenicol/pharmacology , Gene Expression Profiling , Gene Expression Regulation, Bacterial/drug effects , Gene Silencing/drug effects , Genes, Bacterial/genetics , Glutamic Acid/metabolism , Metabolic Networks and Pathways/drug effects , Metabolic Networks and Pathways/genetics , Mutation/genetics , Protein Biosynthesis , Pseudomonas putida/genetics , Pseudomonas putida/growth & development , Putrescine/pharmacology , Up-Regulation/drug effects , Up-Regulation/genetics
7.
Bioorg Med Chem Lett ; 21(9): 2631-6, 2011 May 01.
Article in English | MEDLINE | ID: mdl-21269825

ABSTRACT

The synthesis and structure-activity relationship (SAR) of a novel series of di-substituted imidazoles, derived from modification of DAPT, are described. Subsequent optimization led to identification of a highly potent series of inhibitors that contain a ß-amine in the imidazole side-chain resulting in a robust in vivo reduction of plasma and brain Aß in guinea pigs. The therapeutic index between Aß reductions and changes in B-cell populations were studied for compound 10 h.


Subject(s)
Alzheimer Disease , Amyloid Precursor Protein Secretases/antagonists & inhibitors , Enzyme Activation/drug effects , Enzyme Inhibitors/chemical synthesis , Enzyme Inhibitors/pharmacology , Imidazoles/chemical synthesis , Imidazoles/pharmacology , Amination/drug effects , Amyloid beta-Peptides/blood , Amyloid beta-Peptides/metabolism , Animals , Biological Assay , Diamide/chemical synthesis , Diamide/chemistry , Diamide/pharmacology , Enzyme Inhibitors/chemistry , Guinea Pigs , HeLa Cells , Humans , Imidazoles/chemistry , Inhibitory Concentration 50 , Molecular Structure , Structure-Activity Relationship
8.
Molecules ; 15(8): 5581-94, 2010 Aug 13.
Article in English | MEDLINE | ID: mdl-20714314

ABSTRACT

Lanthionine (Lan), the thioether analog of cystine, is a natural but nonproteogenic amino acid thought to form naturally in mammals through promiscuous reactivity of the transsulfuration enzyme cystathionine-beta-synthase (CbetaS). Lanthionine exists at appreciable concentrations in mammalian brain, where it undergoes aminotransferase conversion to yield an unusual cyclic thioether, lanthionine ketimine (LK; 2H-1,4-thiazine-5,6-dihydro-3,5-dicarboxylic acid). Recently, LK was discovered to possess neuroprotective, neuritigenic and anti-inflammatory activities. Moreover, both LK and the ubiquitous redox regulator glutathione (gamma-glutamyl-cysteine-glycine) bind to mammalian lanthionine synthetase-like protein-1 (LanCL1) protein which, along with its homolog LanCL2, has been associated with important physiological processes including signal transduction and insulin sensitization. These findings begin to suggest that Lan and its downstream metabolites may be physiologically important substances rather than mere metabolic waste. This review summarizes the current state of knowledge about lanthionyl metabolites with emphasis on their possible relationships to LanCL1/2 proteins and glutathione. The potential significance of lanthionines in paracrine signaling is discussed with reference to opportunities for utilizing bioavailable pro-drug derivatives of these compounds as novel pharmacophores.


Subject(s)
Alanine/analogs & derivatives , Central Nervous System/metabolism , Sulfides/metabolism , Alanine/chemistry , Alanine/metabolism , Amination/drug effects , Animals , Central Nervous System/drug effects , Cystathionine beta-Synthase/metabolism , Humans , Neuroprotective Agents/pharmacology , Substrate Specificity/drug effects , Sulfides/chemistry
9.
J Biomed Mater Res A ; 93(3): 1043-9, 2010 Jun 01.
Article in English | MEDLINE | ID: mdl-19753622

ABSTRACT

Growth factor tethering has significant potential to mediate cellular responses in biomaterials and tissue engineering. We have previously demonstrated that epidermal growth factor (EGF) can be tethered to polydimethylsiloxane (PDMS) substrates and that these surfaces promoted interactions with human corneal epithelial cells in vitro. The goal of the current work was to better understand the specific effects of the tethered growth factor on the cells. The EGF was reacted with a homobifunctional N-hydroxysuccinimide (NHS) polyethylene glycol (PEG) derivative, and then bound to allyamine plasma-modified PDMS. Human corneal epithelial cells were seeded on the surfaces and cultured in serum-free medium for periods of up to 5 days. Cell growth was monitored and quantified by trypsinization and counting with a Coulter counter. Expression of matrix proteins and alpha(6)-integrins was assessed by immunostaining and confocal microscopy. A centrifugation assay was used to determine cell adhesion under an applied detachment force. Binding of EGF was found to significantly increase cell numbers and coverage across the surfaces at 5 days of culture in vitro. Immunofluorescence experiments indicate increased expression of fibronectin, laminin, and alpha(6)-integrins on the EGF-modified surfaces, and expression is localized at the cell-material interface as observed by confocal microscopy. In accordance with these results, the highest quantity of adherent cells is found on the EGF-modified subtrates at 5 days of culture. The results provide initial evidence that binding of EGF may be used to improve the epithelialization of and the adhesion of the cells on a polymeric artificial cornea device.


Subject(s)
Dimethylpolysiloxanes/pharmacology , Epidermal Growth Factor/pharmacology , Epithelial Cells/cytology , Epithelial Cells/drug effects , Epithelium, Corneal/cytology , Amination/drug effects , Cell Adhesion/drug effects , Cell Count , Cell Proliferation/drug effects , Epithelial Cells/metabolism , Fibronectins/metabolism , Fluoresceins/metabolism , Fluorescence , Humans , Integrin alpha6/metabolism , Laminin/metabolism , Microscopy, Confocal , Polyethylene Glycols/pharmacology , Surface Properties/drug effects
10.
Org Biomol Chem ; 7(22): 4753-62, 2009 Nov 21.
Article in English | MEDLINE | ID: mdl-19865713

ABSTRACT

Various human illnesses, including several types of cancer and infectious diseases, are related to changes in the cellular redox homeostasis. During the last decade, several approaches have been explored which employ such disturbed redox balances for the benefit of therapy. Compounds able to modulate the intracellular redox state of cells have been developed, which effectively, yet also selectively, appear to kill cancer cells and a range of pathogenic microorganisms. Among the various agents employed, certain redox catalysts have shown considerable promise since they are non-toxic on their own yet develop an effective, often selective cytotoxicity in the presence of the 'correct' intracellular redox partners. Aminoalkylation, amide coupling and multicomponent reactions are suitable synthetic methods to generate a vast number of such multifunctional catalysts, which are chemically diverse and, depending on their structure, exhibit various interesting biological activities.


Subject(s)
Antioxidants/chemical synthesis , Selenium/chemistry , Tellurium/chemistry , Alkylation/drug effects , Amides/chemistry , Amination/drug effects , Antioxidants/pharmacology , Binding Sites , Cell Death/drug effects , Cell Line, Tumor , Humans , Microbial Sensitivity Tests , Oxidation-Reduction/drug effects , Parasitic Sensitivity Tests , Plasmodium falciparum/cytology , Plasmodium falciparum/drug effects , Trichophyton/drug effects
11.
Biol Pharm Bull ; 28(3): 510-4, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15744079

ABSTRACT

Absorption enhancers, which increase the permeability of drugs through epithelial membranes without damaging them, are especially useful for intranasal administration of peptide drugs. In this study, aminated gelatins, candidate enhancers, having different numbers of amino groups were prepared from gelatin (H-gelatin, isoelectric point = 9.0, MW 100 kDa) and a partial gelatin hydrolysate (L-gelatin, isoelectric point = 8.0, MW 5 kDa), and the enhancing effects on the nasal absorption of insulin, used as a model peptide drug, and 5(6)-carboxyfluorescein (CF), a paracellular marker, were examined in rats. The enhancing effect on insulin and CF depends on the MW and number of amino groups. A high correlation between the enhancing effects on insulin and CF was observed and this suggests that an increase in the paracellular permeability is the mechanism governing the nasal absorption-enhancement of aminated gelatins, at least as far as insulin and CF are concerned. The enhancing mechanism might be shared with other cationic polymers having absorption-enhancing effects.


Subject(s)
Gelatin/metabolism , Insulin/metabolism , Nasal Mucosa/drug effects , Nasal Mucosa/metabolism , Administration, Intranasal , Amination/drug effects , Animals , Gelatin/administration & dosage , Gelatin/blood , Insulin/administration & dosage , Insulin/blood , Male , Rats , Rats, Wistar
12.
J Am Chem Soc ; 123(2): 193-8, 2001 Jan 17.
Article in English | MEDLINE | ID: mdl-11456503

ABSTRACT

Nonenzymatic pyridoxal phosphate (PLP) catalyzed decarboxylations and transaminations have been revisited experimentally. Metal ions are known to catalyze a variety of PLP-dependent reactions in solution, including transamination. It is demonstrated here that the rate accelerations previously observed are due solely to enhancement of Schiff base formation under subsaturating conditions. A variety of metal ions were tested for their effects on the reactivity of the 2-methyl-2-aminomalonate Schiff bases. All were found to have either no effect or a small inhibitory one. The effects of Al(3+) were studied in detail with the Schiff bases of 2-methyl-2-aminomalonate, 2-aminoisobutyrate, alanine, and ethylamine. The decarboxylation of 2-methyl-2-aminomalonate is unaffected by metalation with Al(3+), while the decarboxylation of 2-aminoisobutyrate is inhibited 125-fold. The transamination reaction of ethylamine is 75-fold slower than that of alanine. Ethylamine transamination is inhibited 4-fold by Al(3+) metalation, while alanine transamination is inhibited only 1.3-fold. Metal ion inhibition of Schiff base reactivity suggests a simple explanation for the lack of known PLP dependent enzymes that make direct mechanistic use of metal ions. A comparison of enzyme catalyzed, PLP catalyzed, and uncatalyzed reactions shows that PLP dependent decarboxylases are among the best known biological rate enhancers: decarboxylation occurs 10(18)-fold faster on the enzyme surface than it does free in solution. PLP itself provides the lion's share of the catalytic efficiency of the holoenzyme: at pH 8, free PLP catalyzes 2-aminoisobutyrate decarboxylation by approximately 10(10)-fold, with the enzyme contributing an additional approximately 10(8)-fold.


Subject(s)
Carboxy-Lyases/metabolism , Pyridoxal Phosphate/metabolism , Alanine/metabolism , Aluminum/antagonists & inhibitors , Aluminum/pharmacology , Amination/drug effects , Aminoisobutyric Acids/metabolism , Carboxy-Lyases/chemistry , Catalysis , Cations , Decarboxylation/drug effects , Ethylamines/metabolism , Kinetics
13.
Metabolism ; 49(8): 1071-7, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10954028

ABSTRACT

To assess the ability of patients with homocystinuria due to cystathionine beta-synthase (CBS) deficiency to perform the reactions of the methionine transamination pathway, the concentrations of the products of this pathway were measured in plasma and urine. The results clearly demonstrate that CBS-deficient patients develop elevations of these metabolites once a threshold near 350 micromol/L for the concurrent plasma methionine concentration is exceeded. The absence of elevated methionine transamination products previously reported among 16 CBS-deficient B6-responsive patients may now be attributed to the fact that in those patients the plasma methionine concentrations were below this threshold. The observed elevations of transamination products were similar to those observed among patients with isolated hypermethioninemia. Plasma homocyst(e)ine did not exert a consistent effect on transamination metabolites, and betaine appeared to effect transamination chiefly by its tendency to elevate methionine. Even during betaine administration, the transamination pathway does not appear to be a quantitatively major route for the disposal of methionine.


Subject(s)
Cystathionine beta-Synthase/deficiency , Homocystinuria/blood , Methionine/blood , Adolescent , Adult , Aged , Amination/drug effects , Betaine/therapeutic use , Child , Child, Preschool , Female , Homocysteine/blood , Homocystinuria/drug therapy , Homocystinuria/urine , Humans , Infant , Lipotropic Agents/therapeutic use , Male , Methionine/urine , Middle Aged , Transaminases/metabolism
14.
Fiziol Zh (1994) ; 45(6): 51-8, 1999.
Article in Ukrainian | MEDLINE | ID: mdl-10687083

ABSTRACT

It have been found that intraperitoneal alpha-ketoglutarate injection (20 mg/100 g body weight) results in increase in the influence of cholinergic regulation mechanisms. It also results in increase of aminotransferase activity on background of the decrease of succinate dehydrogenase activity in liver and pancreas tissues and in small intestines mucous. Activity of transamination enzymes and succinate dehydrogenase activity is much higher in the case of rats with high hypoxia resistance, alpha-ketoglutarate injection results in increase of transamination enzymes activity in the organisms of rats with low resistance to hypoxia up to the control level of rats with high resistance, and simultaneously increases rats resistance to hypoxia. Effect of alpha-ketoglutarate injection on the energetical exchange in the tissues with different parasympathetic dependence taking from the animals with different hypoxia resistance is suppressed by blockade of M- and H-cholinoceptors.


Subject(s)
Hypoxia/enzymology , Ketoglutaric Acids/pharmacology , Succinate Dehydrogenase/drug effects , Transaminases/drug effects , Amination/drug effects , Animals , Digestive System/drug effects , Digestive System/enzymology , Energy Metabolism/drug effects , Immunity, Innate/drug effects , Rats , Succinate Dehydrogenase/metabolism , Transaminases/metabolism
15.
Radiats Biol Radioecol ; 38(3): 405-10, 1998.
Article in Russian | MEDLINE | ID: mdl-9682735

ABSTRACT

The activity of aspartate aminotransferase, glutamate dehydrogenase in the liver of rats in 1, 7 and 15 days after gamma irradiation effect of the dose of 0.5 Gy on the background of consumption by animals of sodium nitrate, sodium nitrite and nitrosodiethylamine was studied. The combined influence of chemical agents and gamma irradiation modified the effects of nitro compounds-xenobiotics on processes of the synthesis and dissociation of the glutamic acid as well as the intensity of transamination of the reamination by aspartate aminotransferase.


Subject(s)
Aspartate Aminotransferases/drug effects , Aspartate Aminotransferases/radiation effects , Glutamate Dehydrogenase/drug effects , Glutamate Dehydrogenase/radiation effects , Glutamic Acid/metabolism , Glutamic Acid/radiation effects , Nitro Compounds/pharmacology , Amination/drug effects , Amination/radiation effects , Analysis of Variance , Animals , Aspartate Aminotransferases/metabolism , Deamination/drug effects , Deamination/radiation effects , Gamma Rays , Glutamate Dehydrogenase/metabolism , Liver/drug effects , Liver/enzymology , Liver/radiation effects , Male , Rats , Time Factors
16.
Kidney Int ; 50(4): 1195-201, 1996 Oct.
Article in English | MEDLINE | ID: mdl-8887278

ABSTRACT

The distinctive feature of the renal function and metabolism implicate a possibility of excessive ATP degradation during insufficient oxygen supply. Protection of the purine ring against degradation is one among other functions of the purine nucleotide cycle (PNC). The purpose of this study was to estimate the activity of PNC in cytosol of rat renal cortex and medulla under conditions that mimic normal and low oxygen supply in vivo. In normoxic-like condition the rate of AMP deamination was 1.7 and 2.0 nmol/mg protein/min in the cytosol of cortex and medulla, respectively. Under this condition, the rate of IMP reamination was similar to that of AMP deamination. In a hypoxia-like condition the rate of AMP deamination increased by 41% in cytosol from both parts of the kidney, while the rate of IMP reamination remained unchanged in the cytosol of medulla and decreased by 46% in the cortex cytosol. Distribution of the other enzymes of the PNC, that is, adenylosuccinate synthetase and adenylosuccinate lyase, in the cytosol of cortex and medulla correlated with that observed for AMP deamination and IMP reamination potentials. At 150 microM IMP, the activity of adenylosuccinate synthetase in the cortex and medulla was 0.34 and 1.24 nmol/mg protein/min, respectively. Activity of the adenylosuccinate lyase was severalfold greater than the respective activity of the adenylosuccinate synthetase. These results show that the efficiency of PNC is about twice as high in the medulla cytosol as in the cortex cytosol, and that the activity of PNC in kidney is mainly limited by the activity of adenylosuccinate synthetase and supply of AMP.


Subject(s)
Hypoxia/metabolism , Kidney Cortex/metabolism , Kidney Medulla/metabolism , Purine Nucleotides/metabolism , Adenine Nucleotides/metabolism , Adenylosuccinate Lyase/pharmacokinetics , Adenylosuccinate Synthase/pharmacokinetics , Amination/drug effects , Ammonia/metabolism , Animals , Coformycin/pharmacology , Deamination/drug effects , Dose-Response Relationship, Drug , Kidney Cortex/drug effects , Kidney Medulla/drug effects , Male , Rats , Rats, Wistar , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...